Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.

The drug quells seizures in children with Dravet syndrome or Lennox-Gastaut syndrome.

The field of ABA needs more compassion and individualization.

Prenatal exposure to topiramate increases a child’s autism odds, according to the study that prompted the inquiry, but experts caution that pregnant people with epilepsy have few other options for controlling seizures.

Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.

Interventions that moderate a need for ‘sameness’ may prevent anxiety traits.

Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Most autistic children in the Netherlands have used some sort of treatment, but the number, type and timing varies depending on considerations unrelated to their condition.

When the federal public health emergency expires, so too could temporary insurance coverage of applied behavior analysis conducted remotely. A proposed rule could block those changes, however, at least for people with public insurance.

A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.